Limited Period Offer:Be a PRO for 1 month @Rs49/-Multiple payment options available. Know More

Laurus Labs Q2 PAT may dip 49.4% YoY to Rs. 24.5 cr: Sharekhan

Net Sales are expected to increase by 9.9 percent Y-o-Y (up 9.9 percent Q-o-Q) to Rs. 592.5 crore, according to Sharekhan.

October 17, 2018 / 11:25 AM IST
Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Sharekhan has come out with its second quarter (July-September’ 18) earnings estimates for the Pharma sector. The brokerage house expects Laurus Labs to report net profit at Rs. 24.5 crore down 49.4% year-on-year (up 55.1% quarter-on-quarter).


Net Sales are expected to increase by 9.9 percent Y-o-Y (up 9.9 percent Q-o-Q) to Rs. 592.5 crore, according to Sharekhan.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Moneycontrol News

stay updated

Get Daily News on your Browser
Sections